M45.8, Ankylosing spondylitis sacral and sacrococcygeal regionICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
J5
WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts
J5
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6
A52423, Billing and Coding: Infliximab and biosimilars
J6
WPS-J8-L37205, Chemotherapy Drugs and their Adjuncts
J8
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
NGS-JK-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
JK
A59766, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JL
A57206, Billing and Coding: Lumbar MRI
A56695, Billing and Coding: Implantable Infusion Pump
A57689, Billing and Coding: Lab: Flow Cytometry
A57791, Billing and Coding: Spinal Cord Stimulators for Chronic Pain
A58865, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A56432, Billing and Coding: Infliximab
A59374, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A53065, Billing and Coding: Outpatient Physical Therapy
Ask Backwork about documentation requirements, denial risks, or coverage in your state.